Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC33H35FN2O5 |
InChIKeyXUKUURHRXDUEBC-KAYWLYCHSA-N |
CAS Registry134523-00-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dyslipidemias | Phase 3 | - | - | |
| Dyslipidemias | Phase 3 | - | - |





